164 related articles for article (PubMed ID: 29928378)
1. Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells.
Zargar P; Ghani E; Mashayekhi FJ; Ramezani A; Eftekhar E
Oncol Lett; 2018 Jun; 15(6):10084-10090. PubMed ID: 29928378
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy.
Zargar P; Koochakkhani S; Hassanzadeh M; Ashouri Taziani Y; Nasrollahi H; Eftekhar E
Mol Biol Rep; 2022 Apr; 49(4):2755-2763. PubMed ID: 35088375
[TBL] [Abstract][Full Text] [Related]
3. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
[TBL] [Abstract][Full Text] [Related]
4. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
5. Gambogic acid potentiates the chemosensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting proliferation and inducing apoptosis.
Wei J; Yang P; Li W; He F; Zeng S; Zhang T; Zhong J; Huang D; Chen Z; Wang C; Chen H; Hu H; Cao J
Exp Ther Med; 2017 Feb; 13(2):662-668. PubMed ID: 28352348
[TBL] [Abstract][Full Text] [Related]
6. Acriflavine enhances radiosensitivity of colon cancer cells through endoplasmic reticulum stress-mediated apoptosis.
Lim MJ; Ahn JY; Han Y; Yu CH; Kim MH; Lee SL; Lim DS; Song JY
Int J Biochem Cell Biol; 2012 Aug; 44(8):1214-22. PubMed ID: 22564437
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
[TBL] [Abstract][Full Text] [Related]
8. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
9.
Zhang W; Ou L; Peng C; Sang S; Feng Z; Zou Y; Yuan Y; Li H; Zhang G; Yao M
Heliyon; 2023 Jun; 9(6):e16798. PubMed ID: 37484409
[TBL] [Abstract][Full Text] [Related]
10. MiR
Lin Y; Wang W; Wang Y; Fu K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):356-368. PubMed ID: 37164919
[TBL] [Abstract][Full Text] [Related]
11. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
Wang K; Liu W; Xu Q; Gu C; Hu D
Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
[TBL] [Abstract][Full Text] [Related]
12. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin Analog [V
Sobol NT; Solerno LM; Llavona C; Alonso DF; Garona J
World J Oncol; 2023 Dec; 14(6):540-550. PubMed ID: 38022396
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
15. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
Qin Y; Chen X; Liu Z; Tian X; Huo Z
Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
[TBL] [Abstract][Full Text] [Related]
16. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
17. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
18. Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells
Wang Y; Yuan S; Li L; Yang D; Xu C; Wang S; Zhang D
Oncol Lett; 2017 Jun; 13(6):4762-4768. PubMed ID: 28599477
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3.
Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of the efficacy and potential genotoxic hazard of combined SAHA and 5-FU treatment in the chemoresistant colorectal cancer cell lines.
Bálintová L; Matúšková M; Gábelová A
Mutat Res Genet Toxicol Environ Mutagen; 2022; 874-875():503445. PubMed ID: 35151424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
